未分离的氨酸通过抑制DRp1-介导的线粒体质量失衡来提高败血症预后
Ruixue Liu1, He Huang1, Dongyao Hou1,2
1Department of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University, No. 76, Linjiang Road, Yuzhong District, Chongqing, 400010, P. R. China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|October 24, 2024
概括
不分离的肝素 (UFH) 通过非抗凝剂作用提供败血症保护,特别是通过结合Drp1蛋白来保护线粒体. 这改善了败血症模型的结果,提出了新的治疗策略.
科学领域:
- 生物医学研究的研究.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 不分离的肝素 (UFH) 是治疗败血症的标准抗凝剂.
- UFH表现出非抗凝性质,其机制尚不清楚.
- 临床数据表明,UFH提供了除了抗凝血之外的败血症保护.
研究的目的:
- 阐明UFH在败血症中的非抗凝机制.
- 为了研究UFH与Drp1蛋白的相互作用.
- 评估UFH对毒症中线粒体的保护作用.
主要方法:
- 追溯临床数据分析.
- 重组蛋白芯片选,表面等离子体共振和分子对接.
- 在血管内皮细胞和 in-vivo 败血症大鼠模型上的体外实验.
主要成果:
- UFH通过其非抗凝固分段特别与Drp1蛋白结合.
- 结合Drp1的UFH抑制了其在败血症中的线粒体转移.
- UFH改善线粒体形态,功能和新陈代谢,减少血管泄漏并改善败血症预后.
结论:
- UFH在败血症中具有显著的非抗凝剂保护作用.
- 准UFH-Drp1相互作用为败血症提供了一个新的治疗策略.
- UFH的非抗凝性质是其败血症治疗潜力的关键.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
01:29Venous Thrombosis III: Interprofessional Care
2
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
2